Sleep, Insulin Sensitivity, and Weight in Adolescents Post-bariatric Surgery

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04202731

Enrollment

Registered

2019-12-18

Start date

2019-11-20

Completion date

2023-07-14

Last updated

2023-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep

Brief summary

Assessing sleep and circadian health in severely obese adolescents undergoing bariatric surgery and examine relation to health outcomes including insulin sensitivity and percent weight loss to date at 1-year and evaluate the impact of sleep extension on health outcomes in this population.

Interventions

BEHAVIORALPBS Study

Sleep extension intervention

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

12 Years to 21 Years

Healthy volunteers

Yes

Inclusion criteria

* ages 12-21 years * attending high school or middle school (peak period for insufficient and delayed sleep) * completion of bariatric surgery procedure (i.e., vertical sleeve gastrectomy) within the past 2 years but not less than 6 months prior to study participation * All must also be Tanner Stage 5

Exclusion criteria

* regular use of medications affecting sleep (e.g., stimulants, atypical antipsychotics, melatonin or other sleep aids) or insulin resistance (systemic steroids, other oral diabetes medications) * HbA1c ≥6.5% * intelligence quotient (IQ) \<70 or severe mental illness

Design outcomes

Primary

Measure	Time frame	Description
Sleep duration	1 week	Total sleep time at night in hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026